New policosanol product combines natural cholesterol lowering with omega-3 fatty acids to lower CV risk.
D000924:Anticholesteremic Agents / Q000627:therapeutic use*; D015525:Fatty Acids, Omega-3 / Q000627:therapeutic use*; D006801:Humans; D006937:Hypercholesterolemia / Q000517:prevention & control*; D008517:Phytotherapy; D020521:Stroke / Q000517:prevention & control*
D000924:Anticholesteremic Agents; D015525:Fatty Acids, Omega-3